Table 1

Biochemical analyses specific for the study and in clinical routine when available

Prenatal screeningAt inclusionAt delivery and summary of analyses at discharge*
If taken in clinical routine Human chorionic gonadotropin) (c)
Oestriol (c)
Alpha-fetoprotein (c)
Inhibin A (c)
Pregnancy-associated plasma protein A (c)
Cell-free fetal DNA (c)
If taken in clinical routine
Haemoglobin (c)
Haematocrit (c)
WCC (white cell count) (c)
Platelets (c)
Creatinine (c)
AST (aspartate transaminase) (c)
ALT (alanine transaminase) (c)
Total bilirubin (c)
Albumin (c)
LDH (lactate dehydrogenase) (c)
Haptoglobin (c)
APTT (activated partial thromboplastin time) (c)
PR (prothrombin ratio) (c)
INR (international normalise ratio) (c)
CRP (C reactive protein) (c)
Oxygen saturation (d)
Total leucocyte count (c)
Urinary prot/creat ratio (c)
Fibrinogen (c)
Antithrombin (c)
Specific for the study
Multiplate (b)
NT-pro BNP (c)
Troponin (c)
At delivery specific for the study
Multiplate (b)
Platelets (c)
Troponin (c)
NT-pro BNP (c)
Summary of analyses at discharge if taken in clinical routine
Haemoglobin (g/L) (c)
Platelet count (×109/L) (c)
Urinary protein/creatinine ratio (mg/g) (c)
Creatinine (mmol/L) (c)
AST (IU/L) (c)
ALT (IU/L) (c)
GGT (IU/L) (c)
Total bilirubin (μmol/L) (c)
Albumin (g/L) (c)
LDH (IU/L) (c)
Haptoglobin (mg/dL) (c)
APTT (s) (c)
INR (c)
D-dimer (ug/L) (c)
CRP (mg/L) (c)
  • *Lowest antepartum in hospital/highest antepartum in hospital/lowest value post partum/highest value post partum.